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Editorial on the Research Topic
Immunomodulation of Innate Immune Cells
We are delighted to present this Research Topic for Frontiers in Immunology, focusing on
“Immunomodulation of Innate Immune Cells”. This collective comprises both primary research
articles and reviews of the current literature by experts in the field. Papers included in this collection
highlight recent advances in our understanding of the fundamental mechanisms controlling
activation and regulation of innate immune cells, as well as examine new strategies to study and
manipulate their immunomodulation.
The innate immune system is the hosts primary defense mechanism recognizing external
and inherent danger signals, which range from pathogen-derived molecules to mislocalized or
modified host factors. Physiologically, activation of innate immune cells protects the host from
life-threatening infections and acute tissue damage, however, chronic and unwarranted activation
can lead to numerous disease pathologies. Families of highly conserved germ-line sensor proteins,
known as Pattern Recognition Receptors (PRRs) react to specific danger signals. Downstream
of PRR activation intracellular signaling molecules co-ordinate the production of inflammatory
mediators, such as cytokines, chemokines, and interferons, via the activity of specific transcriptional
programmes or through proteolytic cleavage events. Inflammatory mediators then act to mobilize
recruitment of an army of additional immune cells and facilitates acute inflammatory processes.
In addition to production of inflammatory factors, PRR activation can also elicit other important
cellular responses, including autophagy, metabolic reprogramming, and forms of programmed
cell death.
Sensing of both microbial and host derived nucleic acids by PRRs is a critical function
of the innate immune system. In their comprehensive review, Brisse and Ly. describe and
contrast the RNA sensing retinoic-acid-inducible gene I (RIG-I)-like receptors (RLRs), RIG-I and
MDA-5, including their evolution, structure, mechanism of activation, signaling, and modulation.
Meanwhile, Ribeiro et al., examine the emerging concept of modulation of immune cells by
platelets. Platelets are generally considered non-immune cells that circulate in the blood stream
to primarily initiate clotting and prevent excessive blood loss. In this mini-review the authors detail
the current immunomodulatory mechanisms employed by platelets—ranging from clustering
of microbes to direct contact with monocytes to modulate inflammatory cytokine production.
These specialized events have not only been associated with inflammation but also with altered
cell survival signals and the production of Neutrophil extracellular traps (NETs). Overall, the
fact platelets can induce immunomodulatory events to drive inflammatory disease highlights the
exciting potential to target platelets as an alternative therapeutic approach.
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Dectin-1 is a transmembrane C-type lectin receptor (CLR)
that recognizes β-glucan carbohydrate on the surface of fungi
to elicit an anti-fungal immune response. Thymic stromal
lymphopoietin (TSLP) is a pleiotropic cytokine important in
immune regulationmainly produced by epithelial cells to activate
DCs. In their original research article, Elder et al. demonstrate
that DCs are in fact able to produce large amounts of TSLP
that can down modulate dectin-1-induced immune cytokine
responses. The authors uncover a regulatorymechanismwhereby
TSLPR signaling dampens phosphorylation of the tyrosine
protein kinase, SYK and subsequently reduces HIF-1α-driven IL-
1β expression. These findings implicate dysregulation of TSLP
production in chronic fungal infections.
Pathogen modulation of the host immune response is
widely recognized to facilitate bacterial and viral replication
and dissemination. The mini-review by Wemyss and Pearson
highlights how non-typhoidal Salmonella evades the host innate
immune response via temporal and spatial translocation of
specific type III secretion system effectors that modulate
inflammatory responses and limit or induce programmed
cell death pathways, including apoptosis, necroptosis, and
pyroptosis. In a similar vein, the original research articles
by Tseng et al. and Hughes et al. detail novel regulatory
proteins and post-translational modification events mediated
by pathogen-induced Toll-like receptor (TLR) signaling to
increase infectious burden and cause excessive inflammation.
Thioredoxin-interacting protein (Txnip) primarily functions as
an inhibitor of the antioxidant Thioredoxin system that regulates
a variety of biological processes, including activation of NF-κB.
Tseng et al. detail how Group A Streptococcus (GAS) engagement
of TLR2 induces NOX2-dependent proteasomal degradation of
Txnip via HECT E3 ubiquitin ligase and AMP kinase activity,
and promotes inflammation via excessive cytokine and nitrite
production. Similarly, Hughes et al. document TLR4-driven
upregulation of the E3 ubiquitin ligase, Pellino-1, in response to
LPS and Non-typeable Haemophilus influenza (NTHi) infection.
Pellino-1 plays a critical role in regulating TLR signaling, where it
can trigger degradative (K48-linked ubiquitylation) or activating
signals (K63-linked ubiquitylation). The authors subsequently
show that Pellino-1-deficient mice exhibit increased levels of the
neutrophil Keratinocyte chemoattractant (KC) that is associated
with increased neutrophil infiltrate and reduced NTHi burden
in the lung. Together these two studies highlight how pathogens
modulate molecular events to drive inflammation and infection,
and that targeting the stability of these E3 ubiquitin ligases may
be harnessed therapeutically.
Using single cell analysis, Boribong et al. demonstrates that
pre-exposure to very low doses of LPS can pre-condition
neutrophils, altering their preferential recruitment toward an
endogenous inflammatory stimulus as opposed to a stimulus
mimicking a bacterial infection. Neutrophils can thus adopt
different profiles, altering theirmigratory decisionmaking, which
is dependent on the microenvironment and pathogens they
encounter through their lifetime.
The cytosolic DNA sensor, interferon-inducible protein
(IFI204) (p204, human homolog IF16), is a well-known
sensor of DNA viruses and intracellular bacteria. The original
research article by Chen et al. delves into whether extracellular
Staphylococcus aureus infection is also recognized by IFI204. The
authors report that IFI204 is indeed required for inflammatory
STING-TBK1-NF-κB signaling responses and host defense
against Staphylococcus infection, including the promotion of
extracellular traps.
The role of metabolism in modulating innate immune
cells is undeniable. Monocyte activation and adhesion to the
endothelium are crucial events in inflammation. Lee et al.
studied the metabolic changes upon activation of CD14+CD16–
(classical) monocytes, which are recruited to sites of injury
during acute inflammation, where they adhere to vessels. LPS
stimulation of these cells led to an increase in mTOR regulated
glycolysis, essential for monocyte activation and adhesion. This
increase in glycolysis is similar to the glycolytic profile found
in M1-like macrophages, but an accompanying decrease in
OXPHOS or mitochondrial activity was not observed. A better
understanding of the dynamics of metabolic changes in different
immune cells will be essential for the development of therapies
that focus on metabolic reprograming.
Many immune cells, with macrophages being the most
prominent example, can polarize into different phenotypes, and
assume an anti-inflammatory through to a pro-inflammatory
profile, and include subsets more specialized toward fighting
infection or tumors, inducing tissue remodeling. In this special
issue, the review paper by Yin et al. lists major immunoregulatory
plant polysaccharides and discusses the molecular mechanisms
behind their effect in macrophages. Meanwhile, Yoo et al.
describes how TonEBP, a transcriptional activator in M1-
like macrophages, controls macrophage polarization. TonEBP
suppresses expression of heme oxygenase-1 (HO-1) in M1-
primed macrophages by reducing Nrf2 recruitment to the HO-
1 promoter, which leads to a reduction in HO-1 expression.
This mechanism then promotes induction of the M1 profile
while suppressing the M2-like profile. Simultaneously, epigenetic
regulation of macrophage plasticity has been investigated by
Ruenjaiman et al. comparing classical macrophages that are
capable of producing high amount of proinflammatory cytokines,
with non-classical macrophages, that instead produce high
levels of the key anti-inflammatory cytokine IL-10. In this
study the authors show that active histone H3 Lysine 4
Trimethylation (H3K4me3) marks were increased to a greater
extent in non-classical than classical macrophages. Moreover,
adoptive transfer of non-classical macrophages dampens the
production of proinflammatory cytokines in a mouse sepsis
model, suggesting the potential therapeutic use of these
cells. Ernst et al. have focused their work on murine IL-10
promoter elements mediating synergistic induction by cAMP.
Transcription of IL-10 can be achieved via synergism between
cAMP inducers and LPS signaling, providing a mechanism
that can contribute to limit inflammation at its onset in
specific contexts.
Macrophages are essential players in different pathological
conditions. Silva et al. examined a widespread health issue
represented by low back pain associated with intervertebral disc
(IVD) degeneration. Silva et al. set up a co-culture system able
to provide a simple in vitro model to investigate the interaction
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between macrophages and IVD. This interesting model may
be used to investigate the mechanisms by which macrophages
and IVD cells interact during IVD aging and degeneration,
and to test possible therapeutic tools. Furthermore, Pinto et al.
presented their investigation of tumor-associated macrophages
(TAM) in colorectal cancer (CRC). TAMs are the most abundant
host cells that infiltrate tumors, where they acquire a non-
classical polarization exerting essentially pro-tumoral functions.
By performing immunohistochemical analysis on a series of
CRC patients, Pinto et al., discovered that CD163+ non-
classical macrophages are mostly localized in the invasive
front of the tumor, whereas CD80+ classical macrophages are
located in the normal adjacent mucosa. The results presented
in this paper contribute to an increasing understanding of
macrophage polarization within tumors, which is essential for
the development of novel therapeutic strategies to reprogram
macrophages toward a pro-inflammatory anti-tumor phenotype.
Together, the papers in this collection add new knowledge on
the complex molecular map controlling innate activation, while
also suggesting potential novel therapeutic strategies to modulate
innate immune cells and treat diverse immunopathologies. We
would like to take this opportunity to thank all the reviewers
for their time and input, as well as the authors for their valuable
contributions to this Research Topic.
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